Extend Biosciences has a proprietary platform technology that improves the pharmacokinetic properties of peptide- and protein-based therapeutics. The technology is broadly applicable and feasibility studies have been completed on several distinct proof-of-concept molecules.

The company is entering into strategic alliances with partners to assist in the discovery, development and commercialization of superior therapeutic peptides and proteins.

Please contact us for more information.